Aziyo Biologics: Q2 Earnings Insights

  Aziyo Biologics (NASDAQ:AZYO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

 

Aziyo Biologics (NASDAQ:AZYO) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Aziyo Biologics missed estimated earnings by 23.21%, reporting an EPS of $-0.69 versus an estimate of $-0.56.

Revenue was up $478 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 10.44% drop in the share price the next day.

Here’s a look at Aziyo Biologics’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.62 -0.68 -0.62 -0.53
EPS Actual -0.60 -0.82 -0.81 -0.58
Revenue Estimate 10.78M 11.06M 11.48M 12.04M
Revenue Actual 11.49M 10.86M 11.48M 12.16M

To track all earnings releases for Aziyo Biologics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue

Cannabis-focused biopharmaceutical company Avicanna Inc. announced on Tuesday financial results for the first quarter of fiscal 2024.CEO Aras Azadian called it its "best quarter." In addition to being its first EBITDA-positive quarter, it also saw record gross margins.Azadian credited the results to "the proprietary nature of products and services we offer in Canada."

AVCNF